ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,894 | +85.6% | 13,298 | +131.4% | 0.00% | 0.0% |
| Q2 2023 | $21,490 | +195263.6% | 5,746 | +82.1% | 0.00% | – |
| Q1 2023 | $11 | -89.1% | 3,156 | -85.0% | 0.00% | -100.0% |
| Q4 2022 | $101 | -99.9% | 21,044 | +18.2% | 0.00% | +100.0% |
| Q3 2022 | $102,000 | -38.9% | 17,805 | -24.2% | 0.00% | -50.0% |
| Q2 2022 | $167,000 | +1755.6% | 23,502 | +1709.2% | 0.00% | – |
| Q1 2022 | $9,000 | -18.2% | 1,299 | +3.7% | 0.00% | – |
| Q4 2021 | $11,000 | -95.2% | 1,253 | -81.0% | 0.00% | -100.0% |
| Q3 2021 | $231,000 | +541.7% | 6,589 | +292.0% | 0.01% | +500.0% |
| Q2 2021 | $36,000 | -20.0% | 1,681 | +130.6% | 0.00% | 0.0% |
| Q1 2021 | $45,000 | +221.4% | 729 | +119.6% | 0.00% | – |
| Q4 2020 | $14,000 | – | 332 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |